Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-05-25 @ 11:30 PM
Study NCT ID:
NCT06353360
Status:
RECRUITING
Last Update Posted:
2024-08-09
First Post:
2024-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Sponsor:
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HL-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None